Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial | BMC Cancer | Full Text
Neutrophils, G‐CSF and their contribution to breast cancer metastasis - Mouchemore - 2018 - The FEBS Journal - Wiley Online Library
Does Granulocyte Colony–Stimulating Factor Affect Survival in Patients with Advanced Non-small Cell Lung Cancer? - ScienceDirect
Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support - Annals of Oncology
Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study ...
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative | BMC Pulmonary Medicine | Full
Age is a prognostic factor affecting survival in lung cancer patients
The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non‐small cell lung cancer - Sakaguchi - 2020 - Thoracic Cancer - Wiley Online Library
ppn0516_008_table_a.jpg
The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer | Scientific Reports
Frontiers | GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies ...
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Cancers | Free Full-Text | Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment | HTML
Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors | British Journal of Cancer
Does Granulocyte Colony–Stimulating Factor Affect Survival in Patients with Advanced Non-small Cell Lung Cancer? - ScienceDirect
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer | NEJM
Cancers | Free Full-Text | A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis | HTML
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer | NEJM
Granulocyte Colony-Stimulating Factor Treatment During Radiotherapy Is Associated With Survival Benefit in Patients With Lung Ca
Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial | BMC Cancer | Full Text
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma | Journal for ImmunoTherapy of Cancer
Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes - Clinical Lung Cancer
